Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Similar documents
Mahindra & Mahindra. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Bharat Petroleum Corporation

Coal India. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Britannia Industries

Hindalco Industries. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Jindal Steel & Power

Tata Motors. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

HDFC Standard Life Insurance

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Jindal Steel & Power

Source: Company Data; PL Research

ICICI Prudential Life Insurance

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Glenmark Pharmaceuticals

LIC Housing Finance. Source: Company Data; PL Research

Mindtree. Source: Company Data; PL Research.

Dabur India. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research

Tata Steel. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Cig volumes surprise. Source: Company Data; PL Research

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

HCL Technologies. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

Aurobindo Pharma. Source: Company Data; PL Research

Punjab National Bank

Britannia Industries

Dr. Reddy's Laboratories

FY20E FY21E FY20E FY21E

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Cadila Healthcare. Source: Company Data; PL Research

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Cadila Healthcare. Source: Company Data; PL Research

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Dr. Reddy's Laboratories

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Larsen & Toubro (LT IN)

Marico. Source: Company Data; PL Research

Source: Company Data; PL Research

Pantaloon Retail India

IDEA RESEARCH. Q2FY19 Result Update Tuesday, November 13, Mold Tek Packaging Lower gross margins & higher interest cost impacts profitability

Transcription:

Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as on July 25, 2016) Trading data Market Cap. (Rs bn) 113.4 Shares o/s (m) 209.9 3M Avg. Daily value (Rs m) 104.3 Major shareholders Promoters 60.48% Foreign 20.41% Domestic Inst. 8.33% Public & Other 10.78% Stock Performance (%) 1M 6M 12M Absolute (1.7) 18.7 29.9 Relative (8.1) 4.0 29.9 How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2017 36.9 38.4 4.1 2018 40.4 42.9 5.7 Price Performance (RIC:MBFL.BO, BB:MPHL IN) (Rs) 700 600 500 400 300 200 100 0 Jul 15 Sep 15 Nov 15 Source: Bloomberg Jan 16 Mar 16 May 16 Jul 16 Mphasis Q1FY17 revenues and margins were largely in line with expectations. HP revenues declined ~4% QoQ; however, it is likely to stabilize in Q2/Q3. Direct International business had healthy deal wins of US$96m in Q1FY17 post US$303m worth deals in FY16. We believe with HP revenue stabilizing (post Blackstone deal) and steady outlook in non HP business, Mphasis is likely to reverse the trend of revenue decline witnessed in the past five years. We forecast 1%/6% YoY USD revenue growth in FY17/18 with ~110bps margin expansion over FY16 18. Clarity on revenue opportunity from Blackstone investee companies will emerge by H2FY17, which will provide upside to FY18 estimates. Q1FY17 USD EBIT growth of 15% YoY with margin expansion of 71/253bps QoQ/YoY is heartening in our view, given the margin pressure faced by most of its peers. Management has also outlined EBIT Margin range of 14 16% for FY17 (earlier for H1FY17) with QoQ margin expansion in Q2FY17. We retain BUY with TP of Rs570 based on 14x FY18 EPS. Overall in line results: Mphasis reported flat USD revenue growth at US$225.6m (PLe: $228.0m, Cons.: $226.0m). EBITDA grew by 2.7% QoQ and 16% YoY largely in line with expectations. EBITDA margins, however, increased by 41/198 QoQ/YoY, respectively, to 16.1% (PLe: 16.1%, Cons: 16%). Adjusted Net profit came slightly ahead of our estimates. Adj. EPS grew 6.4% QoQ to Rs9.7 (PLe: Rs9.4, Cons.: Rs9.2). HP business close to bottoming out: HP Channel declined 4.2% QoQ/22% YoY, though the QoQ decline was lower compared to last few quarters. Management indicated that HP business will stabilise by Q2FY17. Direct International revenues grew by 1.5% QoQ to US$162.8m, up 8% YoY and would be the company s key area of focus, going ahead. Healthy deal wins in Direct International channel: Deal wins continue to be healthy, with US$96m worth deals signed in Q1FY17 in Direct International channel (Q4FY16: US$76m). We believe the revenue contribution from the Direct International business will be able to offset the drop in HP revenues. Key financials (Y/e March) 2015 2016 2017E 2018E Revenues (Rs m) 57,803 60,740 62,752 66,786 Growth (%) (8.5) 5.1 3.3 6.4 EBITDA (Rs m) 8,555 8,831 9,525 10,433 PAT (Rs m) 6,746 7,159 7,746 8,495 EPS (Rs) 32.1 34.1 36.9 40.4 Growth (%) (7.2) 6.1 8.2 9.7 Net DPS (Rs) 16.0 24.2 25.4 Profitability & Valuation 2015 2016 2017E 2018E EBITDA margin (%) 14.8 14.5 15.2 15.6 RoE (%) 12.7 12.3 12.2 12.8 RoCE (%) 11.6 11.2 11.2 11.8 EV / sales (x) 2.0 1.8 1.7 1.6 EV / EBITDA (x) 13.5 12.4 11.2 10.1 PE (x) 16.8 15.9 14.7 13.4 P / BV (x) 2.1 1.8 1.8 1.7 Net dividend yield (%) 3.0 4.5 4.7 Source: Company Data; PL Research Q1FY17 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

Exhibit 1: USD Revenue growth to turn positive Exhibit 2: USD EBIT growth YoY $ Revenue growth YoY $ EBIT growth YoY 8.0% 6.0% 4.0% 2.0% 2.0% 4.0% 6.4% 1.2% 1.9% FY16 FY17E FY18E 12.0% 1 8.0% 6.0% 4.0% 2.0% 2.0% 9.8% 6.0% 0.4% FY16 FY17E FY18E Exhibit 3: USD Revenue growth YoY on quarterly basis US $ Revenue growth (YoY) 1 8.0% 6.0% 4.0% 2.0% 2.0% 4.0% 6.0% 8.0% 1 7.8% 6.0% 1.0% 1.1% 1.9% 3.9% 3.5% 7.4% 7.6% 6.5% 6.0% 5.7% Exhibit 4: USD EBIT growth YoY on quarterly basis $ EBIT growth YoY 3 2 1 6.6% 2.1% 22.0% 15.2% 1.0% 8.2% 7.5% 10.3% 9.9% 11.7% 1 2.6% 2 3 21.4% July 25, 2016 2

Exhibit 5: Q1FY17: Revenues and margins largely in line with expectations Q1FY17 Q4FY16 QoQ Q1FY16 YoY Cons PLe Variance Consolidated Sales (USD m) 225.6 225.0 0.3% 235 3.9% 226 228 0.8% Consolidated Sales (Rs m) 15,167 15,160 14,945 1.5% 15,285 15,218 0.3% EBITDA (Rs m) 2,445 2,381 2.7% 2,113 15.7% 2,449 2,447 0.1% EBITDA Margin 16.1% 15.7% 14.1% 198 16.0% 16.1% PBT (Rs m) 2,827 2,643 7.0% 2,269 24.6% 2,702 2,738 3.3% Tax (Rs m) 784 723 8.4% 611 28.3% 761 753 4.1% Tax Rate 27.7% 27.4% 38 26.9% 80 28.2% 27.5% 23 PAT (Rs m) 2,043 1,920 6.4% 1,658 23.2% 1,941 1,985 2.9% EPS (Rs) 9.7 9.1 6.4% 7.9 23.2% 9.2 9.4 3.1% Exhibit 6: USD revenue decline YoY 2.0% 2.0% 4.0% 6.0% 8.0% 1 12.0% 14.0% US $ Revenue growth (YoY) 1.1% 1.0% 1.4% 3.9% 5.8% 6.0% 7.8% 11.2% 11.5% Q1FY15 Q2FY15 Q3FY15 Q4FY15 Exhibit 7: Double digit USD EBIT Growth YoY $ EBIT growth YoY 3 2 1 1 6.6% 2.1% 22.0% 15.2% 2 3 21.4% July 25, 2016 3

Exhibit 8: Company has delivered on EBIT margin guidance given last quarter (14 16%) EBIT Margins 16.0% 15.0% 15.2% 14.5% 15.2% 14.0% 13.0% 12.6% 12.8% 11.7% 12.7% 13.6% 12.9% 12.0% 11.0% 1 Q1FY15 Q2FY15 Q3FY15 Q4FY15. Exhibit 9: Highest TCV in the last five quarters TCV (US$ mn) 120 100 80 60 76 90 61 76 96 40 20 0. Exhibit 10: Revenues from HP on a declining trend, however, revenues to stabilise Q2FY17 onwards HP revenue (US$mn) 250 200 150 183 188 191 170 158 159 138 134 122 120 100 109 103 95 93 90 86 78 71 67 63 55 55 52 50 July 25, 2016 4

Exhibit 11: Direct International revenue on a growing trend Direct International (US$ mn) 170.0 160.0 150.0 140.0 130.0 143.4 140.0 129.5 139.2 150.3 157.6 161.2 160.4 162.8 120.0 110.0 100.0 Q1FY15 Q2FY15 Q3FY15 Q4FY15. Exhibit 12: Revenue decline in ICE and Insurance Revenue (US$ m) Q1FY17 Q4FY16 QoQ Q1FY16 YoY Banking and Capital Market 109.7 108.9 0.8% 103.9 5.6% Insurance 34.2 36.3 5.8% 36.2 5.5% Information, Comm. & Ent. (ICE) 23.0 24.1 4.7% 33.6 31.5% Emerging Industries 57.6 55.8 3.2% 60.6 4.9% % of Total Banking and Capital Market 48.6% 48.4% 24 bps 44.2% 441 bps Insurance 15.1% 16.1% 98 bps 15.4% 26 bps Information, Comm. & Ent. (ICE) 10.2% 10.7% 54 bps 14.3% 410 bps Emerging Industries 25.5% 24.8% 73 bps 25.8% 25 bps Exhibit 13: Revenue decline across segments except Direct International By Secondary Market (US$ m) Q1FY17 Q4FY16 QoQ Q1FY16 YoY HP Channel 52.5 54.8 4.2% 67.4 22.2% Direct International 162.8 160.4 1.5% 150.3 8.3% Others 9.2 10.1 8.5% 16.7 45.0% Exhibit 14: BPO realizations improve YoY aided by divestiture of India BPO Price Movement(USD/hr) Q1FY17 Q4FY16 QoQ Q1FY16 YoY Onsite Applications 76 76 71 7.0% Onsite ITO 68 67 1.5% 62 9.7% Offshore Applications 21 22 4.5% 21 Offshore BPO 10 10 6 66.7% Offshore ITO 19 18 5.6% 20 5.0% July 25, 2016 5

Exhibit 15: Decline in >US$5m client bucket Customer Size Distribution Q1FY17 Q4FY16 QoQ Q1FY16 YoY >1m 102 103 1.0% 98 4.1% >5m 28 35 2 36 22.2% >10m 15 14 7.1% 20 25.0% >20m 9 8 12.5% 8 12.5% Exhibit 16: Headcount decline in Offshore ITO and Onsite BPO People Management Q1FY17 Q4FY16 QoQ Q1FY16 YoY Onsite Applications 2,340 2,322 0.8% 2,366 1.1% Onsite BPO 1,236 1,359 9.1% 1,646 24.9% Onsite ITO 215 212 1.4% 169 27.2% Offshore Applications 8,495 8,441 0.6% 8,261 2.8% Offshore BPO 5,682 5,511 3.1% 16,093 64.7% Offshore ITO 3,158 3,209 42.7% 4,244 25.6% Total Headcount Onsite 3,791 3,893 2.6% 4,181 9.3% Total Headcount Offshore 17,335 17,161 1.0% 28,598 39.4% Sales and Marketing 289 300 3.7% 316 8.5% General and Administration 943 948 0.5% 1,041 9.4% Overall Headcount 22,358 22,302 0.3% 34,136 34.5% Utilization (excluding Trainees) Blended Application 85.0% 84.0% 100 bps 88.0% 300 bps BPO 94.0% 89.0% 500 bps 78.0% 1600 bps ITO 94.0% 91.0% 300 bps 94.0% 0 bps Exhibit 17: India was the exception with QoQ revenue decline Geo Spread Q1FY17 Q4FY16 QoQ Q1FY16 YoY Americas 173.9 172.9 0.6% 173.4 0.3% EMEA 24.2 24.1 0.5% 23.1 4.6% India 14.6 15.0 3.0% 22.9 36.4% RoW 13.0 13.0 0.1% 15.4 15.6% Total 226 225 0.3% 235 3.9% % of Total America 77.1% 76.9% 21 bps 73.8% 323 bps Europe 10.7% 10.7% 2 bps 9.9% 88 bps India 6.5% 6.7% 22 bps 9.8% 330 bps RoW 5.8% 5.8% 1 bps 6.6% 80 bps Total 10 10 0 bps 10 0 bps July 25, 2016 6

Exhibit 18: Growth in AMS. ADM, Customer service and Technical helpdesk decline sharply Practices Q1FY17 Q4FY16 QoQ Q1FY16 YoY Application Maintenance & Services 80.4 76.8 4.7% 68.3 17.8% Application Development 52.0 55.1 5.6% 58.1 10.5% Costumer Service 4.2 4.6 8.2% 12.4 66.4% Service/Technical Help Desk 4.7 5.1 8.4% 4.6 2.4% Transaction Processing Services 15.7 16.0 2.1% 15.3 2.4% Infrastructure Management Services 30.6 30.5 0.3% 35.0 12.6% Knowledge Process + Licenses 36.9 36.9 40.4 8.7% % of revenue Application Maintenance & Services 35.6% 34.1% 149 bps 29.1% 657 bps Application Development 23.0% 24.5% 145 bps 24.7% 169 bps Costumer Service 1.9% 2.0% 17 bps 5.3% 345 bps Service/Technical Help Desk 2.1% 2.3% 20 bps 2.0% 13 bps Transaction Processing Services 7.0% 7.1% 17 bps 6.5% 43 bps Infrastructure Management Services 13.6% 13.6% 1 bps 14.9% 135 bps Knowledge Process + Licenses 16.4% 16.4% 5 bps 17.2% 85 bps Exhibit 19: Client Metrics Q1FY17 Q4FY16 QoQ Q1FY16 YoY Customer Concentration Top Customer 24.8 24.7 0.3% 21.1 17.4% Top 5 88.0 85.5 2.9% 82.2 7.0% Top 2 5 63.2 60.7 4.0% 61.1 3.5% Top 6 10 56.4 54.0 4.5% 49.3 14.4% Top 10 119.6 114.7 4.2% 110.4 8.3% Non Top 10 customers 106.0 110.2 3.8% 124.5 14.8% Top Customer 11.0% 11.0% 0 bps 9.0% 200 bps Top 5 39.0% 38.0% 100 bps 35.0% 400 bps Top 10 53.0% 51.0% 200 bps 47.0% 600 bps Non Top 10 customers 47.0% 49.0% 200 bps 53.0% 600 bps July 25, 2016 7

Exhibit 20: Decline in revenue from Fixed Price Projects (FPP) Service Delivery Q1FY17 Q4FY16 QoQ Q1FY16 YoY Revenue from T&M 179.9 177.8 1.2% 205.7 12.5% Revenue from FPP 45.7 47.1 3.1% 29.2 56.6% Onsite Revenue 115.3 115.7 0.4% 115.8 0.4% Offshore Revenue 110.3 109.2 1.0% 119.0 7.3% % of Total Revenue from T&M 79.7% 79.0% 70 bps 87.6% 783 bps Revenue from FPP 20.3% 21.0% 70 bps 12.4% 783 bps Onsite Revenue 51.1% 51.5% 34 bps 49.3% 180 bps Offshore Revenue 48.9% 48.5% 34 bps 50.7% 180 bps Exhibit 21: USD revenue growth trend Exhibit 22: INR Revenue movement over the last few quarters Revenue (US$ m) (LHS) QoQ Gr. YoY Gr. Revenue (Rs m) (LHS) QoQ Gr. YoY Gr. 240 235 230 225 220 215 4% 2% 0% 2% 4% 6% 8% 15600 15400 15200 15000 14800 14600 10% 8% 6% 4% 2% 0% 2% 4% Source: PL Research, Company Data Source: PL Research, Company Data Exhibit 23: EBITDA growth and margin trend Exhibit 24: PAT growth trend over the course of last few quarters 17% 16% EBITDA Margin (LHS) EBITDA gr. YoY EBITDA gr. QoQ 30% 20% 3 2 QoQ YoY 15% 10% 1 14% 13% 12% 0% 10% 20% 1 2 July 25, 2016 8

Income Statement (Rs m) Y/e March 2015 2016 2017E 2018E Net Revenue 57,803 60,740 62,752 66,786 Raw Material Expenses 43,424 45,175 45,503 48,243 Gross Profit 14,379 15,565 17,250 18,543 Employee Cost Other Expenses 5,824 6,734 7,724 8,109 EBITDA 8,555 8,831 9,525 10,433 Depr. & Amortization 980 744 769 818 Net Interest Other Income 1,833 1,737 1,928 2,102 Profit before Tax 9,408 9,824 10,685 11,717 Total Tax 2,630 2,665 2,938 3,222 Profit after Tax 6,778 7,159 7,746 8,495 Ex Od items / Min. Int. 32 Adj. PAT 6,746 7,159 7,746 8,495 Avg. Shares O/S (m) 210.1 210.2 210.2 210.2 EPS (Rs.) 32.1 34.1 36.9 40.4 Cash Flow Abstract (Rs m) Y/e March 2015 2016 2017E 2018E C/F from Operations 5,954 7,040 9,420 8,375 C/F from Investing (3,816) (1,207) (1,351) (1,514) C/F from Financing (1,998) (5,081) (5,336) Inc. / Dec. in Cash 141 5,833 2,987 1,526 Opening Cash 3,532 4,035 9,868 12,855 Closing Cash 4,035 9,868 12,855 14,381 FCFF 7,584 6,588 8,068 6,862 FCFE 7,941 6,588 8,068 6,862 Key Financial Metrics Y/e March 2015 2016 2017E 2018E Growth Revenue (%) (8.5) 5.1 3.3 6.4 EBITDA (%) (25.5) 3.2 7.9 9.5 PAT (%) (7.1) 6.1 8.2 9.7 EPS (%) (7.2) 6.1 8.2 9.7 Profitability EBITDA Margin (%) 14.8 14.5 15.2 15.6 PAT Margin (%) 11.7 11.8 12.3 12.7 RoCE (%) 11.6 11.2 11.2 11.8 RoE (%) 12.7 12.3 12.2 12.8 Balance Sheet Net Debt : Equity (0.1) (0.1) (0.1) Net Wrkng Cap. (days) Valuation PER (x) 16.8 15.9 14.7 13.4 P / B (x) 2.1 1.8 1.8 1.7 EV / EBITDA (x) 13.5 12.4 11.2 10.1 EV / Sales (x) 2.0 1.8 1.7 1.6 Earnings Quality Eff. Tax Rate 28.0 27.1 27.5 27.5 Other Inc / PBT 19.5 17.7 18.0 17.9 Eff. Depr. Rate (%) 9.0 6.6 6.1 5.8 FCFE / PAT 117.7 92.0 104.2 80.8. Balance Sheet Abstract (Rs m) Y/e March 2015 2016 2017E 2018E Shareholder's Funds 54,798 61,958 64,623 67,782 Total Debt 5,753 5,753 5,753 5,753 Other Liabilities 500 500 500 500 Total Liabilities 61,051 68,211 70,876 74,035 Net Fixed Assets 1,874 2,337 2,919 3,615 Goodwill 21,781 21,781 21,781 21,781 Investments 23,606 23,606 23,606 23,606 Net Current Assets 12,964 19,763 21,845 24,309 Cash & Equivalents 4,034 9,868 12,855 14,381 Other Current Assets 21,805 23,258 22,796 24,621 Current Liabilities 12,875 13,363 13,805 14,693 Other Assets 826 826 826 826 Total Assets 61,051 68,313 70,978 74,137 Quarterly Financials (Rs m) Y/e March Q2FY16 Q3FY16 Q4FY16 Q1FY17 Net Revenue 15,519 15,122 15,160 15,167 EBITDA 2,289 2,121 2,381 2,445 % of revenue 14.7 14.0 15.7 16.1 Depr. & Amortization 179 167 181 137 Net Interest Other Income 473 448 443 519 Profit before Tax 2,583 2,402 2,643 2,827 Total Tax 683 666 723 784 Profit after Tax 1,847 1,736 1,604 2,043 Adj. PAT 1,900 1,736 1,604 2,043 Key Operating Metrics Y/e March 2015 2016 2017E 2018E Revenue (US$ m) 944 926 937 997. July 25, 2016 9

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 60% 50% 40% 30% 20% 10% 0% 48.7% 36.5% 14.8% BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Govind Agarwal, B.E. and PG Diploma in Management, Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Govind Agarwal, B.E. and PG Diploma in Management, Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. July 25, 2016 10